122
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Prognostic Value of Wagner Grade and Platelet Level in Diabetics with Infected Foot Ulcers After Antibiotic Therapy

, , ORCID Icon, , , & ORCID Icon show all
Pages 7435-7445 | Received 19 Sep 2023, Accepted 30 Nov 2023, Published online: 04 Dec 2023

References

  • International Diabetes Federation. IDF diabetes atlas. 9th edition. Brussels, Bel Gium Atlas. Brussels, Belgium: IDF Diabetes; 2019. Available from: https://www.diabetesatlas.org. Accessed December 1, 2023.
  • Brechow A, Slesaczeck T, Münch D, et al. Improving major amputation rates in the multicomplex diabetic foot patient: focus on the severity of peripheral arterial disease. Ther Adv Endocrinol Metab. 2013;4(3):83–94. doi:10.1177/2042018813489719
  • Crawford F, Cezard G, Chappell FM; PODUS Group. The development and validation of a multivariable prognostic model to predict foot ulceration in diabetes using a systematic review and individual patient data meta-analyses. Diabet Med. 2018;35(11):1480–1493. doi:10.1111/dme.13797
  • Kaminski MR, Raspovic A, McMahon LP, et al. Risk factors for foot ulceration and lower extremity amputation in adults with end-stage renal disease on dialysis: a systematic review and meta-analysis. Nephrol Dial Transplant. 2015;30(10):1747–1766. doi:10.1093/ndt/gfv114
  • Gordois A, Scuffham P, Shearer A, Oglesby A, Tobian JA. The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care. 2003;26(6):1790–1795. doi:10.2337/diacare.26.6.1790
  • Gazzaruso C, Gallotti P, Pujia A, Montalcini T, Giustina A, Coppola A. Predictors of healing, ulcer recurrence and persistence, amputation and mortality in type 2 diabetic patients with diabetic foot: a 10-year retrospective cohort study. Endocrine. 2021;71(1):59–68. doi:10.1007/s12020-020-02431-0
  • Ugwu E, Adeleye O, Gezawa I, Okpe I, Enamino M, Ezeani I. Predictors of lower extremity amputation in patients with diabetic foot ulcer: findings from MEDFUN, a multi-center observational study. J Foot Ankle Res. 2019;12:34. doi:10.1186/s13047-019-0345-y
  • Reiber GE, Vileikyte L, Boyko EJ, et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care. 1999;22(1):157–162. doi:10.2337/diacare.22.1.157
  • Lazarus GS, Cooper DM, Knighton DR, Percoraro RE, Rodeheaver G, Robson MC. Definitions and guidelines for assessment of wounds and evaluation of healing. Wound Repair Regen. 1994;2(3):165–170. doi:10.1046/j.1524-475X.1994.20305.x
  • Natarajan S, Williamson D, Stiltz AJ, Harding K. Advances in wound care and healing technology. Am J Clin Dermatol. 2000;1(5):269–275. doi:10.2165/00128071-200001050-00002
  • Velnar T, Bailey T, Smrkolj V. The wound healing process: an overview of the cellular and molecular mechanisms. J Int Med Res. 2009;37(5):1528–1542. doi:10.1177/147323000903700531
  • Weck M, Slesaczeck T, Paetzold H, et al. Structured health care for subjects with diabetic foot ulcers results in a reduction of major amputation rates. Cardiovasc Diabetol. 2013;12(1):45. doi:10.1186/1475-2840-12-45
  • Cahn A, Elishuv O, Olshtain-Pops K. Establishing a multidisciplinary diabetic foot team in a large tertiary hospital: a workshop. Diabetes Metab Res Rev. 2014;30(5):350–353. doi:10.1002/dmrr.2527
  • Sanders LJ, Robbins JM, Edmonds ME. History of the team approach to amputation prevention: pioneers and milestones. J Vasc Surg. 2010;52(3 Suppl):3S–16S. doi:10.1016/j.jvs.2010.06.002
  • Lipsky BA, Senneville É, Abbas ZG, et al. Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36(Suppl 1):e3280. doi:10.1002/dmrr.3280
  • Ndosi M, Wright-Hughes A, Brown S, et al. Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study. Diabet Med. 2018;35(1):78–88. doi:10.1111/dme.13537
  • Van Olmen J, Marie KG, Christian D, et al. Content, participants and outcomes of three diabetes care programmes in three low and middle income countries. Prim Care Diabetes. 2015;9(3):196–202. doi:10.1016/j.pcd.2014.09.001
  • Quddus MA, Uddin MJ. Evaluation of foot ulcers in diabetic patients. Mymensingh Med J. 2013;22(3):527–532.
  • Markowitz JS, Gutterman EM, Magee G, Margolis DJ. Risk of amputation in patients with diabetic foot ulcers: a claims-based study [published correction appears in Wound Repair Regen. 2007 Jan-Feb; 15(1):163]. Wound Repair Regen. 2006;14(1):11–17. doi:10.1111/j.1743-6109.2005.00083.x
  • Carlson T, Reed JF. A case-control study of the risk factors for toe amputation in a diabetic population. Int J Low Extrem Wounds. 2003;2(1):19–21. doi:10.1177/1534734603002001004
  • Chaturvedi N, Stevens LK, Fuller JH, Lee ET, Lu M. Risk factors, ethnic differences and mortality associated with lower-extremity gangrene and amputation in diabetes. The WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia. 2001;44(Suppl 2):S65–S71. doi:10.1007/pl00002941
  • Monteiro-Soares M, Russell D, Boyko EJ, et al. Guidelines on the classification of diabetic foot ulcers (IWGDF 2019). Diabetes Metab Res Rev. 2020;36(Suppl 1):e3273. doi:10.1002/dmrr.3273
  • Ramakant P, Verma AK, Misra R, et al. Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose? Diabetologia. 2011;54(1):58–64. doi:10.1007/s00125-010-1893-7
  • Mishra SC, Chhatbar KC, Kashikar A, Mehndiratta A. Diabetic foot. BMJ. 2017;359:j5064. doi:10.1136/bmj.j5064
  • Abe R, Oda S, Sadahiro T, et al. Gram-negative bacteremia induces greater magnitude of inflammatory response than Gram-positive bacteremia. Crit Care. 2010;14(2):R27. doi:10.1186/cc8898
  • Giske CG, Monnet DL, Cars O, Carmeli Y; ReAct-Action on on Antibiotic Resistance. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother. 2008;52(3):813–821. doi:10.1128/AAC.01169-07
  • Loonen AJ, de Jager CP, Tosserams J, et al. Biomarkers and molecular analysis to improve bloodstream infection diagnostics in an emergency care unit. PLoS One. 2014;9(1):e87315. doi:10.1371/journal.pone.0087315
  • de Jager CP, van Wijk PT, Mathoera RB, de Jongh-Leuvenink J, van der Poll T, Wever PC. Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Crit Care. 2010;14(5):R192. doi:10.1186/cc9309
  • Ljungström L, Pernestig AK, Jacobsson G, Andersson R, Usener B, Tilevik D. Diagnostic accuracy of procalcitonin, neutrophil-lymphocyte count ratio, C-reactive protein, and lactate in patients with suspected bacterial sepsis. PLoS One. 2017;12(7):e0181704. doi:10.1371/journal.pone.0181704
  • Asik Z. The Role of the NLR and PLR in Urinary Tract Infection. Clin Lab. 2021;67(10). doi:10.7754/Clin.Lab.2021.210133
  • Huang Z, Fu Z, Huang W, Huang K. Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: a meta-analysis. Am J Emerg Med. 2020;38(3):641–647. doi:10.1016/j.ajem.2019.10.023
  • Dos Santos VP, da Silveira DR, Caffaro RA. Risk factors for primary major amputation in diabetic patients. Sao Paulo Med J. 2006;124(2):66–70. doi:10.1590/s1516-31802006000200004
  • Shin JY, Roh SG, Sharaf B, Lee NH. Risk of major limb amputation in diabetic foot ulcer and accompanying disease: a meta-analysis. J Plast Reconstr Aesthet Surg. 2017;70(12):1681–1688. doi:10.1016/j.bjps.2017.07.015
  • International Diabetes Federation. IDF Diabetes Atlas, Eighth Edition 2017; 2018. Available from http://www.diabetesatlas.org. Accessed November 9, 2018.
  • Uçkay I, Gariani K, Pataky Z, Lipsky BA. Diabetic foot infections: state-of-The-art. Diabetes Obes Metab. 2014;16(4):305–316. doi:10.1111/dom.12190
  • Armstrong DG, Boulton AJM, Bus SA, Ingelfinger JR. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017;376(24):2367–2375. doi:10.1056/NEJMra1615439
  • Selva Olid A, Solà I, Barajas-Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database Syst Rev. 2015;2015(9):CD009061. doi:10.1002/14651858.CD009061.pub2
  • Prompers L, Huijberts M, Apelqvist J, et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia. 2007;50(1):18–25. doi:10.1007/s00125-006-0491-1
  • Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen. 2008;16(5):585–601. doi:10.1111/j.1524-475X.2008.00410.x
  • Nurden AT, Nurden P, Sanchez M, Andia I, Anitua E. Platelets and wound healing. Front Biosci. 2008;13:3532–3548. doi:10.2741/2947
  • Seeger MA, Paller AS. The roles of growth factors in keratinocyte migration. Adv Wound Care. 2015;4(4):213–224. doi:10.1089/wound.2014.0540
  • Akingboye AA, Giddins S, Gamston P, Tucker A, Navsaria H, Kyriakides C. Application of autologous derived-platelet rich plasma gel in the treatment of chronic wound ulcer: diabetic foot ulcer. J Extra Corpor Technol. 2010;42(1):20–29. doi:10.1051/ject/201042020
  • Pscherer S, Dippel FW, Lauterbach S, Kostev K. Amputation rate and risk factors in type 2 patients with diabetic foot syndrome under real-life conditions in Germany. Prim Care Diabetes. 2012;6(3):241–246. doi:10.1016/j.pcd.2012.02.004
  • Venermo M, Manderbacka K, Ikonen T, Keskimäki I, Winell K, Sund R. Amputations and socioeconomic position among persons with diabetes mellitus, a population-based register study. BMJ Open. 2013;3(4):e002395. doi:10.1136/bmjopen-2012-002395